OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next‐generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients
Karlien L. M. Coene, Leo A. J. Kluijtmans, E. van der Heeft, et al.
Journal of Inherited Metabolic Disease (2018) Vol. 41, Iss. 3, pp. 337-353
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Genetics of mitochondrial diseases: Identifying mutations to help diagnosis
Sarah L. Stenton, Holger Prokisch
EBioMedicine (2020) Vol. 56, pp. 102784-102784
Open Access | Times Cited: 204

The biology of ergothioneine, an antioxidant nutraceutical
Irina Borodina, Louise C. Kenny, Cathal McCarthy, et al.
Nutrition Research Reviews (2020) Vol. 33, Iss. 2, pp. 190-217
Open Access | Times Cited: 188

Metabolomics: A Scoping Review of Its Role as a Tool for Disease Biomarker Discovery in Selected Non-Communicable Diseases
Adewale Victor Aderemi, Ademola Olabode Ayeleso, O. O. Oyedapo, et al.
Metabolites (2021) Vol. 11, Iss. 7, pp. 418-418
Open Access | Times Cited: 91

Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app
Eva M. M. Hoytema van Konijnenburg, Saskia B. Wortmann, Marina J. Koelewijn, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 89

Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing
Adam D. Kennedy, Bryan M. Wittmann, Anne M. Evans, et al.
Journal of Mass Spectrometry (2018) Vol. 53, Iss. 11, pp. 1143-1154
Closed Access | Times Cited: 88

Genetic basis of mitochondrial diseases
Mirjana Gušić, Holger Prokisch
FEBS Letters (2021) Vol. 595, Iss. 8, pp. 1132-1158
Closed Access | Times Cited: 61

Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism
Ning Liu, Jing Xiao, Charul Gijavanekar, et al.
JAMA Network Open (2021) Vol. 4, Iss. 7, pp. e2114155-e2114155
Open Access | Times Cited: 59

How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques
Saskia B. Wortmann, Machteld M. Oud, Mariëlle Alders, et al.
Journal of Inherited Metabolic Disease (2022) Vol. 45, Iss. 4, pp. 663-681
Open Access | Times Cited: 57

Metabolomics meets systems immunology
Jianbo Fu, Feng Zhu, Cheng‐Jian Xu, et al.
EMBO Reports (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 26

The Metabolic Treatabolome and Inborn Errors of Metabolism Knowledgebase therapy tool: Do not miss the opportunity to treat!
Bibiche den Hollander, Eva M. M. Hoytema van Konijnenburg, Brittany Hewitson, et al.
Journal of Inherited Metabolic Disease (2025) Vol. 48, Iss. 1
Open Access | Times Cited: 1

Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics
Israa T. Ismail, Megan R. Showalter, Oliver Fiehn
Metabolites (2019) Vol. 9, Iss. 10, pp. 242-242
Open Access | Times Cited: 73

The role of the clinician in the multi‐omics era: are you ready?
Clara D.M. van Karnebeek, Saskia B. Wortmann, Maja Tarailo‐Graovac, et al.
Journal of Inherited Metabolic Disease (2018) Vol. 41, Iss. 3, pp. 571-582
Open Access | Times Cited: 70

Direct Infusion Based Metabolomics Identifies Metabolic Disease in Patients’ Dried Blood Spots and Plasma
Hanneke A. Haijes, Marcel Willemsen, Maria van der Ham, et al.
Metabolites (2019) Vol. 9, Iss. 1, pp. 12-12
Open Access | Times Cited: 67

The diagnosis of inborn errors of metabolism by an integrative “multi‐omics” approach: A perspective encompassing genomics, transcriptomics, and proteomics
Sarah L. Stenton, Laura S. Kremer, Robert Kopajtich, et al.
Journal of Inherited Metabolic Disease (2019) Vol. 43, Iss. 1, pp. 25-35
Closed Access | Times Cited: 62

Metabolomics: a challenge for detecting and monitoring inborn errors of metabolism
Michele Mussap, Marco Zaffanello, Vassilios Fanos
Annals of Translational Medicine (2018) Vol. 6, Iss. 17, pp. 338-338
Open Access | Times Cited: 61

Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders
Lindsay C. Burrage, Lillian R Thistlethwaite, Bridget M. Stroup, et al.
Genetics in Medicine (2019) Vol. 21, Iss. 9, pp. 1977-1986
Open Access | Times Cited: 58

The genetics of mitochondrial disease: dissecting mitochondrial pathology using multi‐omic pipelines
Charlotte L. Alston, Sarah L. Stenton, Gavin Hudson, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 430-442
Open Access | Times Cited: 48

Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy
Udo F. H. Engelke, Rianne E. van Outersterp, Jona Merx, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 15
Open Access | Times Cited: 47

Simultaneous Quantitation and Discovery (SQUAD) Analysis: Combining the Best of Targeted and Untargeted Mass Spectrometry-Based Metabolomics
Bashar Amer, Rahul Deshpande, Susan S. Bird
Metabolites (2023) Vol. 13, Iss. 5, pp. 648-648
Open Access | Times Cited: 22

Fast Label‐Free Metabolic Profile Recognition Identifies Phenylketonuria and Subtypes
Haiyang Su, Huiwen Zhang, Jiao Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 7

Metabolomics to Improve the Diagnostic Efficiency of Inborn Errors of Metabolism
Dylan Mordaunt, David J. Cox, Maria Fuller
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1195-1195
Open Access | Times Cited: 41

Metabolomics in Clinical Practice: Improving Diagnosis and Informing Management
John D. Odom, V. Reid Sutton
Clinical Chemistry (2021) Vol. 67, Iss. 12, pp. 1606-1617
Open Access | Times Cited: 38

Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine
Andrea Gropman, Martine Uittenbogaard, Anne Chiaramello
Neurotherapeutics (2024) Vol. 21, Iss. 1, pp. e00311-e00311
Open Access | Times Cited: 5

The clinical relevance of novel biomarkers as outcome parameter in adults with phenylketonuria
Annemiek M. J. van Wegberg, J. C. van der Weerd, Udo F. H. Engelke, et al.
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 4, pp. 624-635
Open Access | Times Cited: 5

Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function
Xiao‐Yan Wen, Maja Tarailo‐Graovac, Koroboshka Brand‐Arzamendi, et al.
JCI Insight (2018) Vol. 3, Iss. 24
Open Access | Times Cited: 45

Page 1 - Next Page

Scroll to top